Page 64 - South Korean (KOSPI) Dividend Stocks

UPDATED Oct 12, 2025

Discover South Korean High Yield Dividend Stocks that are on the KOSPI and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on 'Advanced Filters'.

1,532 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
A012160
Youngwire
₩553.00-1.3%15.0%₩37.7bn/aPB0.2xn/a0%Materials
A002990
KUMHO Engineering & Construction
₩3,660.002.4%17.1%₩133.7b₩4,400.00PB0.6xE112.3%0%Capital Goods
A481850
Shinhan Global Active REIT
₩1,423.00-0.9%-43.0%₩62.3bn/an/an/a0%Real Estate
A357430
MASTERN PREMIER REIT 1
₩1,506.00-0.7%-32.9%₩46.1bn/an/an/a0%Real Estate
A042660
Hanwha Ocean
₩109,200.00-2.1%255.7%₩33.5t₩116,185.00PE39.6xE23.7%0%Capital Goods
A033240
Jahwa Electronics
₩21,250.001.7%24.0%₩442.0b₩21,500.00PB1.1xE62.9%0%Tech
A006400
Samsung SDI
₩210,000.001.7%-41.5%₩16.2t₩236,395.13PS1.2xE62.2%0%Tech
A432320
KB STAR REIT
₩3,980.000.3%-8.2%₩405.2bn/an/an/a0%Real Estate
A293940
Shinhan Alpha REIT
₩5,530.00-0.9%-8.6%₩670.0b₩7,666.67n/an/a0%Real Estate
A085620
MIRAE ASSET Life Insurance
₩8,140.000%55.9%₩1.0t₩6,100.00PE6.7xE-0.05%0%Insurance
A025750
HansolHomeDeco.Co
₩668.00-1.8%-8.2%₩54.2bn/aPB0.4xn/a0%Materials
A003530
Hanwha Investment & Securities
₩5,690.00-3.7%69.6%₩1.3tn/aPE27.2xn/a0%Diversified Financials
A091120
EM-Tech.CO
₩9,590.004.0%-66.7%₩147.0bn/aPB0.8xn/a0%Tech
A024740
Hanil Forging Industrial
₩2,265.00-0.9%1.1%₩75.3bn/aPE25.2xn/a0%Automobiles
A114630
POLARIS UNO
₩497.000%-11.6%₩42.7bn/aPE14xn/a0%Materials
A038460
BioSmartLtd
₩2,925.00-1.2%-30.4%₩73.8bn/aPE42.9xn/a0%Tech
A256630
POINT ENGINEERINGLtd
₩1,080.00-1.6%-22.9%₩62.4bn/aPE66.4xn/a0%Semiconductors
A078890
KAON Group
₩4,120.00-4.0%8.0%₩70.4bn/aPB0.5xn/a0%Tech
A036010
ABCO Electronics
₩9,710.001.4%72.2%₩132.7bn/aPS1xn/a0%Tech
A092040
Amicogen
₩3,680.00-4.7%-10.4%₩209.1bn/aPS1.7xn/a0%Pharmaceuticals & Biotech
Page 64 of 64